Infectious complications in chronic dialysis patients

Peritoneal Dialysis International

Volumn 28, Issue SUPP. 3, 2008, Pages

  Foley, Robert N ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cardiovascular mortality; Pneumonia; Septicemia

Indexed keywords

ANTIBIOTIC AGENT; INFLUENZA VACCINE; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; STAPHYLOCOCCUS VACCINE;

ANTISEPSIS; ARTERIOVENOUS FISTULA; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL EDUCATION; CLINICAL TRIAL; CONFERENCE PAPER; DIALYSIS CATHETER; DISEASE ASSOCIATION; HAZARD RATIO; HEALTH CARE POLICY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION CONTROL; INFECTION RISK; INTERMETHOD COMPARISON; PERITONEAL DIALYSIS; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK REDUCTION; SEPTICEMIA;

BACTERIAL INFECTIONS; CARDIOVASCULAR DISEASES; COMORBIDITY; DISEASE SUSCEPTIBILITY; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; UREMIA;

EID: 48749119579     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Bright R. Cases and observation, illustrative of renal disease accompanied with the secretion of albuminous urine. Guy's Hospital Reports 1836; 1:338-400.
2. Dammin GJ, Couch NP, Murray JE. Prolonged survival of skin homografts in uremic patients. Ann N Y Acad Sci 1957; 64:967-76.
3. Foley RN, Wang C, Collins AJ. Cardiovascular risk factor profiles and kidney function stage in the U.S. general population: the NHANES III study. Mayo Clin Proc 2005; 80:1270-7.
4. Hoyert DL, Heron MP, Murphy SL, Kung HC. Deaths: final data for 2003. Natl Vital Stat Rep 2006; 54:1-120.
5. United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic, and Hematologic Diseases. USRDS 2006 annual data report. Atlas of end-stage renal disease in the United States. Bethesda: United States Renal Data System; 2006.
6. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58:1758-64.
7. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol 2004; 15:1038-45.
8. Marr KA, Sexton DJ, Conton PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127:275-80.
9. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9:869-76.
10. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 2005; 68:311-18.
11. Gupta R, Plantinga LC, Fink NE, Melamed ML, Coresh J, Fox CS, et al. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA 2007; 297:1455-64.
12. Thomson PC, Stirling CM, Geddes CC, Morris ST, Mactier RA. Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and death. QJM 2007; 100:415-22.
13. U.S. NationaL Kidney Foundation (NKF). Home > Professionals > KDOQI > Clinical Practice Guidelines > Vascular Access (Web page; use "Click for more information" link and then the View Guidelines control). New York: NKF; 2006. [Available at: www.kidney.org/ professionals/KDOQI/guideline_upHD_PD_VA/va_guide2.htm; cited 2 January 2008]
14. Peters VJ, Clemons G, Augustine B. "Fistula First" as a CMS breakthrough initiative: improving vascular access through collaboration. Nephrol Nurs J 2005; 32:686-7.
15. Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, et al. on behalf of the Dialysis Outcomes and Practice Patterns Study. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 63:323-30.
16. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Mald DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51:1-29.
17. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991; 40:934-8.
18. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9:1085-92.
19. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17:1802-7.
20. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with Polysporin ointment. J Am Soc Nephrol 2003; 14:169-79.
21. Weijmer MC, van den Dorpet MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, et al. on behalf of the CITRATE Study Group. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005; 16:2769-77.
22. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315:91-6.
23. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001; 120:1883-7.
24. United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic, and Hematologic Diseases. USRDS 2007 annual data report. Atlas of end-stage renal disease in the United States. Bethesda: United States Renal Data System; 2007.
25. D'Agata EM, Mount DB, Thayer V, Schaffner W. Hospital-acquired infections among chronic hemodialysis patients. Am J Kidney Dis 2000; 35:1083-8.
26. Slinin Y, Foley RN, Collins AJ. Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int 2006; 70:1135-41.
27. Guo H, Liu J, Collins AJ, Foley RN. Pneumonia in incident dialysis patients - the United States Renal Data System. Nephrol Dial Transplant 2008; 23:680-6.
28. Advisory Committee on Immunization Practices; Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-42.
29. Kausz AT, Guo H, Pereira BJ, Collins AJ, Gilbertson DT. General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol 2005; 16:3092-101.
30. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-26.
31. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-9.
32. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-43.
33. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-95.
34. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Mäkelä PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2:983-6.
35. Nieto FJ. Infective agents and cardiovascular disease. Semin Vasc Med 2002; 2:401-15.
36. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl Med 2003; 348:138-50.
37. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:1899-911.
38. Kaysen GA, Eiserich JP. Characteristics and effects of inflammation in end-stage renal disease. Semin Dial 2003; 16:438-46.